Sinopharm Group Nantong Co., Ltd. was established in June 1997 with a registered capital of 36 million yuan. It mainly engages in the distribution and delivery of pharmaceuticals, medical devices, diagnostic reagents, and other products, and is a comprehensive pharmaceutical supply chain service provider in the Nantong region. The company joined the Sinopharm system in January 2012 and is a third-tier subsidiary of Sinopharm Group Co., Ltd. It has one subsidiary, Sinopharm Group Nantong Medical Device Co., Ltd., and owns seven self-operated pharmacies under Sinopharm Group Nantong Co., Ltd.: Xinsite Pharmacy Xisi Road Store, Hengkangtang Pharmacy, Huaqiao Pharmacy, Duanpingqiao Pharmacy, Rugao Wandu Pharmacy, Rudong Pharmacy, and Qidong Renyuan Pharmacy, with a total of more than 300 employees.
For many years, the company's sales scale has consistently maintained a leading position among pharmaceutical distributors in the Nantong region. Its direct sales network now covers the entire Nantong City, and its distribution network covers the entire Jiangsu Province. It has been awarded multiple honors, including "Advanced Unit for Drug Safety in Nantong City," "Excellent Enterprise for High-Quality Development in Chongchuan District," "Excellent Enterprise for High-Quality Development in Chongchuan Economic Development Zone," and "Advanced Unit for Tax Contribution in Chongchuan Economic Development Zone."
The company adheres to the guidance of Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era. Under the correct leadership of the Party Committee of Sinopharm Group, the Party Committee of Sinopharm Holdings, and the Party Committee of Sinopharm Jiangsu, it fully grasps the economic environment and policy orientation, proactively responds to industry changes, and on the basis of traditional pharmaceutical distribution, continuously expands its device and retail businesses through business structure adjustment and resource integration, building a diversified pharmaceutical and health ecosystem and enhancing its market competitiveness. In addition, the company always upholds the corporate philosophy of "Protecting Life, Caring for Health," follows the guidance of Sinopharm Holdings' "14th Five-Year" strategic plan, implements the task objectives of "improving quality and increasing efficiency," and continuously strengthens operational control through risk prevention, business innovation, organizational reform, and digital transformation. It consolidates its market position, focuses on its core business, builds a new development pattern, actively fulfills its social responsibilities, and practices the responsibilities of a central state-owned enterprise.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows